These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21863286)

  • 1. Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis.
    Ohta H; Miyashita E; Hirata I; Matsumura R; Yoshida H; Hashii Y; Higashiura T; Yasumi T; Murata Y; Heike T; Yang X; Kanegane H; Ohara O; Ozono K
    Int J Hematol; 2011 Sep; 94(3):285-290. PubMed ID: 21863286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis.
    Lehmberg K; Albert MH; Beier R; Beutel K; Gruhn B; Kröger N; Meisel R; Schulz A; Stachel D; Woessmann W; Janka G; Müller I
    Haematologica; 2014 Jan; 99(1):180-4. PubMed ID: 24162790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
    Marsh RA; Kim MO; Liu C; Bellman D; Hart L; Grimley M; Kumar A; Jodele S; Myers KC; Chandra S; Leemhuis T; Mehta PA; Bleesing JJ; Davies SM; Jordan MB; Filipovich AH
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1625-31. PubMed ID: 24035782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.
    Cooper N; Rao K; Gilmour K; Hadad L; Adams S; Cale C; Davies G; Webb D; Veys P; Amrolia P
    Blood; 2006 Feb; 107(3):1233-6. PubMed ID: 16219800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
    Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation].
    Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720
    [No Abstract]   [Full Text] [Related]  

  • 7. T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Familial Hemophagocytic Lymphohistiocytosis Who Do Not Have Matched Family Donors: Experience in Oman.
    Nazir HF; Ba Alawi FS; Al Hosni S; Al Rawas A; Dennison D
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1119-1123. PubMed ID: 32088369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
    Messina C; Zecca M; Fagioli F; Rovelli A; Giardino S; Merli P; Porta F; Aricò M; Sieni E; Basso G; Ripaldi M; Favre C; Pillon M; Marzollo A; Rabusin M; Cesaro S; Algeri M; Caniglia M; Di Bartolomeo P; Ziino O; Saglio F; Prete A; Locatelli F
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1223-1231. PubMed ID: 29410181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Li Z; Wang Y; Wang J; Zhang J; Wang Z
    Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.
    Marsh RA; Vaughn G; Kim MO; Li D; Jodele S; Joshi S; Mehta PA; Davies SM; Jordan MB; Bleesing JJ; Filipovich AH
    Blood; 2010 Dec; 116(26):5824-31. PubMed ID: 20855862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial hemophagocytic lymphohistiocytosis with the MUNC13-4 mutation after unrelated hematopoietic stem cell transplantation: a case report].
    Tang XF; Luan Z; Wu NH; Zhang B; Wang K
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):944-5. PubMed ID: 24495769
    [No Abstract]   [Full Text] [Related]  

  • 12. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome].
    Sun R; Xiao J; Zhang J; Lu Y; Wei Z; Zhu H; Sun Y
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):94-8. PubMed ID: 24739718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis.
    Kohli S; Rastogi N; Nivargi S; Thakkar D; Katewa S; Yadav SP
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e158-e160. PubMed ID: 30044345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report.
    Yang J; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Ma HH; Qin MQ
    J Clin Immunol; 2020 Aug; 40(6):893-900. PubMed ID: 32627096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine/Melphalan 100 mg/m
    Park HS; Lee JH; Lee JH; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1116-1121. PubMed ID: 30508593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide in Pediatric Hemophagocytic Lymphohistiocytosis.
    Medina-Valencia D; Cleves D; Beltran E; Builes N; Franco AA; Escobar-González AF; Olaya M
    J Clin Immunol; 2021 Aug; 41(6):1172-1177. PubMed ID: 33687579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning.
    Wustrau K; Greil J; Sykora KW; Albert MH; Burkhardt B; Lang P; Meisel R; Wössmann W; Beier R; Schulz A; Bader P; Chada M; Kühl JS; Schlegel PG; Speckmann C; Gruhn B; Seidel M; Wawer A; Ozga AK; Janka G; Ehl S; Müller I; Lehmberg K
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28523. PubMed ID: 32618429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults.
    He L; Wang Y; Suolitiken D; Zhang R; Liu M; Hua Z; Yao S; Zou H; Wang Z
    Hematol Oncol; 2022 Aug; 40(3):390-399. PubMed ID: 35526261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.
    Orozco JJ; Kenoyer A; Balkin ER; Gooley TA; Hamlin DK; Wilbur DS; Hylarides MD; Frost SH; Mawad R; O'Donnell P; Sandmaier BM; Fuchs EJ; Luznik L; Green DJ; Gopal AK; Press OW; Pagel JM
    Blood; 2016 Jan; 127(3):352-9. PubMed ID: 26576864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.